NORTH CHICAGO, Ill., Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago ...

Even when a drug finishes its production in the U.S., its active and inactive components often come from overseas. While pharmaceutical companies have been unveiling plans for new U.S. manufacturing ...

AbbVie today announced a $1.4 billion investment to build a new drug production facility on a 185-acre campus in Durham County, where the company expects to employ 734 people. The company’s ...

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ...

The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...

On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ — The pharmaceutical industry is undergoing a period of rapid evolution, driven by global health ...

Highly potent active pharmaceutical ingredients (HPAPIs) are at the forefront of pharmaceutical manufacturing. They are particularly common in targeted therapies and personalized medicines. This is ...

NORTH CHICAGO, Ill., Feb. 23, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at ...

Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity Pilot (QMM) program ...

April 22 (Reuters) - AbbVie will invest $1.4 billion to build a manufacturing campus in North Carolina, the drugmaker said on ...

Investment marks continued progress against AbbVie's $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade Two new ...